COSCIENS Biopharma Inc. (CSCIF) Operating margin 2016–2025
COSCIENS Biopharma Inc. (CSCIF) operating margin by fiscal year — reported operating income divided by reported revenue.
-142.5%FY2025 · since FY2016: -3235.6% → -142.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -142.5% | +48.2 pp |
| FY2024 | -190.7% | -125.9 pp |
| FY2023 | -64.8% | -94.5 pp |
| FY2022 | 29.6% | +194.5 pp |
| FY2021 | -164.8% | -8.6 pp |
| FY2020 | -156.2% | +1768.9 pp |
| FY2019 | -1925.2% | -1961.8 pp |
| FY2018 | 36.6% | +2536.5 pp |
| FY2017 | -2499.9% | +735.7 pp |
| FY2016 | -3235.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice